RhumbLine Advisers’s PMV Pharmaceuticals PMVP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-23,035
| Closed | -$37.3K | – | 4303 |
|
|
2024
Q2 | $37.3K | Sell |
23,035
-39,693
| -63% | -$64.3K | ﹤0.01% | 3759 |
|
|
2024
Q1 | $107K | Buy |
62,728
+2,980
| +5% | +$5.07K | ﹤0.01% | 3431 |
|
|
2023
Q4 | $185K | Sell |
59,748
-1,646
| -3% | -$5.1K | ﹤0.01% | 3223 |
|
|
2023
Q3 | $377K | Buy |
61,394
+80
| +0.1% | +$491 | ﹤0.01% | 2790 |
|
|
2023
Q2 | $384K | Buy |
61,314
+3,316
| +6% | +$20.8K | ﹤0.01% | 2861 |
|
|
2023
Q1 | $277K | Buy |
57,998
+1,584
| +3% | +$7.57K | ﹤0.01% | 2641 |
|
|
2022
Q4 | $491K | Buy |
56,414
+755
| +1% | +$6.57K | ﹤0.01% | 2470 |
|
|
2022
Q3 | $662K | Buy |
55,659
+2,838
| +5% | +$33.8K | ﹤0.01% | 2367 |
|
|
2022
Q2 | $753K | Buy |
52,821
+25,131
| +91% | +$358K | ﹤0.01% | 2280 |
|
|
2022
Q1 | $577K | Buy |
27,690
+1,983
| +8% | +$41.3K | ﹤0.01% | 2358 |
|
|
2021
Q4 | $594K | Buy |
25,707
+896
| +4% | +$20.7K | ﹤0.01% | 2441 |
|
|
2021
Q3 | $739K | Buy |
24,811
+1,257
| +5% | +$37.4K | ﹤0.01% | 2366 |
|
|
2021
Q2 | $805K | Buy |
23,554
+9,536
| +68% | +$326K | ﹤0.01% | 2340 |
|
|
2021
Q1 | $461K | Buy |
14,018
+90
| +0.6% | +$2.96K | ﹤0.01% | 2530 |
|
|
2020
Q4 | $857K | Buy |
+13,928
| New | +$857K | ﹤0.01% | 2211 |
|